在所有阶段的非小细胞肺癌中对KRAS突变的分子表征
Carla Climent1, Sandra Soriano1, Natalia Lopez1
1Department of Medical Oncology, Consorcio Hospital Universitario Parc Tauli, Sabadell 08208, Spain.
Ecancermedicalscience
|June 25, 2025
概括
在非小细胞肺癌 (NSCLC) 中的基斯鼠肉瘤病毒 (KRAS) 突变与转移风险有关,特别是在早期阶段. 评估KRAS亚型对于个性化治疗策略和更密切的患者监测至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 基尔斯大鼠肉瘤病毒 (KRAS) 突变 (KRASm) 在非小细胞肺癌 (NSCLC) 腺癌病例的约25%中存在.
- 下一代测序 (NGS) 允许详细识别KRASm亚型,揭示不同的预后和共同突变模式.
研究的目的:
- 研究KRASm患者在NSCLC所有阶段的临床和病理特征.
- 在NSCLC患者中分析KRASm亚型,共突变和PD-L1表达.
主要方法:
- 2019-2021年对123名NSCLC患者的分析,使用52基因向NGS小组对DNA和RNA变异进行分析.
- 使用SP263抗体对PD-L1表达的评估.
主要成果:
- 在50.4%的患者中发现了KRASm,其中G12C,G12V和G12D是最常见的亚型.
- G12C和G12V亚型与转移性疾病显著相关 (p=0.004).
- 在24.2%的患者中检测到共变异;PIK3CA是最常见的. 在19.4%的患者中观察到PD-L1表达>50%.
结论:
- KRAS状态和亚型评估在NSCLC中至关重要,特别是在早期疾病中,因为它们与转移风险有关.
- 研究结果表明,这对治疗策略和对高风险患者的更密切监测具有潜在的相关性.
- PD-L1状态可能是KRASm患者的预后因素,需要进一步调查.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
相关概念视频
02:38The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K
01:24Small GTPases - Ras and Rho
4.3K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.3K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K